A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma

NCT00002319 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Doxorubicin hydrochloride (liposomal)

Sponsor

Sequus Pharmaceuticals